Researcher
Leen SLAETS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Diagnostics not elsewhere classified, Applied immunology, Autoimmunity, Neurosciences not elsewhere classified, Immunomodulation therapy, Biogerontology
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Jul 2017 → Today - Biomedical Research Institute (Research institute)
Member
From1 Jul 2017 → Today - Physiology - Biochemistry - Immunology (Department)
Member
From1 Jul 2017 → 31 Dec 2019 - Immunology - Biochemistry (Research group)
Member
From1 Jul 2017 → 31 Dec 2019 - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Oct 2009 → 30 May 2016 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Feb 2009 → 30 May 2016 - Medical Basic Sciences (Division)
Member
From1 Feb 2009 → 30 Sep 2009 - Immunology - Biochemistry (Research group)
Member
From20 Jul 2005 → 30 May 2016 - Biomedical Research Institute (Research institute)
Member
From16 Sep 2004 → 30 May 2016
Projects
1 - 8 of 8
- Cellular Senescence: an Underestimated Player in the Pathology of MS.From1 Jan 2024 → TodayFunding: Foundations, funds and other with scientific goal
- Associations between immunosenescence and cellular senescence as determinants of aging and pathology.From19 Dec 2023 → TodayFunding: BOF - projects
- Immune protective effects of exercise: sex mattersFrom1 Nov 2023 → TodayFunding: FWO fellowships
- Deep immune-phenotyping of multiple sclerosis patients using advanced spectral flow cytometryFrom1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- Multiple sclerosis, a multidisciplinary approachFrom1 Jan 2015 → 31 Dec 2019Funding: FWO scientific research network
- Oncostatin M as a Master Regulator of MS Lesion RepairFrom1 Jan 2014 → 31 Dec 2016Funding: Foundations, funds and other with scientific goal
- Oncostatin M: a master regulator of MS lesion repairFrom1 Jan 2012 → 31 Dec 2015Funding: FWO research grant KAN
- Oncostatin M as a master regulator of central nervous system lesion pathologyFrom1 Jan 2011 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 27
- Train your T cells: How skeletal muscles and T cells keep each other fit during aging(2023)
Authors: Leen SLAETS, Lena FONTEYN, Bert OP 'T EIJNDE, Niels HELLINGS
Pages: 237 - 244 - Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial(2021)
Authors: Lucas Wauters, Leen SLAETS, Kim De Paepe, Matthias Ceulemans, Suzan WETZELS, Karlien Geboers, Joran Toth, Wannes Thys, Raf Dybajlo, Daan Walgraeve, et al.
Pages: 784 - 792 - Oncostatin m-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination(2020)
Authors: Evelien HOUBEN, Kris JANSSENS, Doryssa HERMANS, J. Vandooren, C. Van den Haute, Melissa SCHEPERS, Tim VANMIERLO, Ivo LAMBRICHTS, V. Baekelandt, Jack VAN HORSSEN, et al.
Pages: 32 - 33 - A data-driven approach for detecting gait events during turning in people with Parkinson's disease and freezing of gait(2020)
Authors: Benjamin Filtjens, Alice Nieuwboer, Nicholas D'cruz, Joke SPILDOOREN, Leen SLAETS, Bart VANRUMSTE
Pages: 130 - 136 - Oncostatin M-induced astrocytic TIMP-1 enables remyelination(2018)
Authors: Evelien HOUBEN, Kim JANSSENS, Ivo LAMBRICHTS, V. Baekelandt, Melissa SCHEPERS, Tim VANMIERLO, Leen SLAETS, Bieke BROUX, Niels HELLINGS
Pages: 201 - 202 - Tolerogenic Dendritic Cells Generated by In Vitro Treatment With SAHA Are Not Stable In Vivo(2016)
Authors: Kristof THEWISSEN, Bieke BROUX, Jerome HENDRIKS, Mandy Vanhees, Piet STINISSEN, Leen SLAETS, Niels HELLINGS
Pages: 1207 - 1218 - Oncostatin M protects against demyelination by inducing a protective microglial phenotype.(2015)
Authors: Kris JANSSENS, Anurag MAHESHWARI, C. Van den Haute, Veerle Baekelandt, Piet STINISSEN, Jerome HENDRIKS, Leen SLAETS, Niels HELLINGS
Pages: 1729 - 1737 - Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis(2015)
Authors: Kris JANSSENS, C. Van den Haute, Veerle Baekelandt, S. Lucas, Jack VAN HORSSEN, Bart VAN WIJMEERSCH, Piet STINISSEN, Niels HELLINGS, Jerome HENDRIKS, Leen SLAETS, et al.
Pages: 180 - 188 - Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosis(2015)
Authors: Kris JANSSENS, Leen SLAETS, Niels HELLINGS
Pages: 52 - 60 - Leukemia inhibitory factor shifts the immune balance towards regulatory T cells(2014)
Authors: Kris JANSSENS, Chris Van den Haute, Veerle Baekelandt, Jack VAN HORSSEN, Bart VAN WIJMEERSCH, Piet STINISSEN, Jerome HENDRIKS, Leen SLAETS, Niels HELLINGS
Pages: 155 - 155